Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about LILLY DRN

Recent news which mentions LILLY DRN

< Previous 1 2 3 Next >
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
Tags US: News Pharmaceuticals LILLY DRN
From CNBC.com News
Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars
Tags Health & Science LILLY DRN Companies
From CNBC.com News
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
Tags Earnings Health care industry Novo Nordisk A/S
From CNBC.com News
Novo Nordisk posts net profit beat as Wegovy sales jump 107% in fourth quarter
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Europe Economy
From CNBC.com News
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
Tags Biotech and Pharmaceuticals Science Novo Nordisk A/S
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Investing Chipotle Mexican Grill Inc 5 Things to Know
From CNBC.com News
Reid Hoffman enters 'wondrous and terrifying' world of health care with latest AI startup
Tags Health care industry Breaking News: Technology Hospitals
From CNBC.com News
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
Tags stocks Investment Strategy Business News
From CNBC.com News
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
Tags Business Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Food-as-medicine startups hope Kennedy, if confirmed as HHS secretary, will boost their businesses
Tags Nutrition Health care industry CVS Health Corp
From CNBC.com News
Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
Tags Pfizer Inc Breaking News: Politics Health care industry
From CNBC.com News
'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
Tags Policy Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Tags Internet IQVIA Holdings Inc Walgreens Boots Alliance Inc
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags LILLY DRN Merck & Co Inc Health & Science
From CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Tags Biogen Inc Biotechnology Health care industry
From CNBC.com News
Jim Cramer says he supports healthcare stocks for their long-term value
Tags Business Regeneron Pharmaceuticals Inc Markets
From CNBC.com News
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
Tags Iovance Biotherapeutics Inc Biotech and Pharmaceuticals KemPharm Inc
From CNBC.com News
Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand
Tags Business Biotech and Pharmaceuticals Earnings
From CNBC.com News
Eli Lilly CEO expects new weight loss pill to be approved next year
Tags Business Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
Tags Zillow Group Inc Novo Nordisk A/S Business
From CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Business
From CNBC.com News
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
Tags Amgen Inc Health care industry Madrigal Pharmaceuticals Inc
From CNBC.com News
Cramer's Lightning Round: Uber is a buy
Tags Lazard Ltd Stock markets Mad Money
From CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Tags Weight management Companies Health & Science
From CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
Tags Business Science Novo Nordisk A/S
From CNBC.com News
5 things to know before the stock market opens Friday
Tags Technology Economy Markets
From CNBC.com News
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage
Tags Business News US: News Pharmaceuticals
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags Health & Science LILLY DRN Healthy Returns
From CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Amazon/com Inc
From CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
Tags Cybersecurity Technology Novo Nordisk A/S
From CNBC.com News
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.